Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now presents the NCT03664232 autism study record, including its eligibility criteria, treatment arms, outcome measures, study locations, results-related dates, and study documents, instead of a 403 error.
    Difference
    55%
    Check dated 2026-11-08T23:20:11.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T23:26:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The clinical trial record itself continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-25T22:39:42.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T23:01:30.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:13:29.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden error instead of the expected content, indicating the page is currently inaccessible and preventing access to trial details.
    Difference
    19%
    Check dated 2026-09-20T22:09:39.000Z thumbnail image

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.